Radio Compass Blog | Pharmaceutical Articles at Pharmacompass.com

#Blog

FDA halts production at J&J’s vaccine contractor for unsafe practices; Thermo Fisher picks up PPD for US$ 17.4 billion

This week, Phispers brings you an update on Johnson & Johnson’s contract manufacturer Emergent BioSolutions, which recently faced an FDA inspection at its Baltimore plant, following contamination of 15 million doses of the J&J jab ...

2021-04-22

#Phispers by PHARMACOMPASS

#Blog

Vaccine cocktails in the works: UK, China, France consider mixing jabs; India bans exports of remdesivir

This week, Phispers brings you a host of trends from across the globe pertaining to Covid vaccines. Countries like the UK, China and France are talking about mixing vaccines to boost their efficacy. After AstraZeneca, Johnson & Johnson’s si...

2021-04-15

#Phispers by PHARMACOMPASS

#Blog

Europe confirms link between Astra jab and clots; Baltimore plant mixes ingredients of J&J, Astra shots

AstraZeneca-Oxford’s Covid-19 vaccine has received many setbacks over the last few months, and this week’s Phispers brings you more updates. While the European drugs regulator has confirmed a link between the vaccine and the ‘...

2021-04-08

#Phispers by PHARMACOMPASS

#Blog

Novartis shutters plant of world’s costliest drug; Bharat Biotech’s vaccine rejected by Anvisa due to GMP concerns

This week, Phispers brings you more news on Covid vaccines. In the US, while Pfizer and BioNTech said their vaccine was 100 percent effective in preventing Covid-19 in 12 to 15 year olds, public health agency CDC came out with a report on messenger R...

2021-04-01

#Phispers by PHARMACOMPASS

#Blog

Chinese prices of APIs increase dramatically; former Operation Warp Speed head accused of sexual harassment

This week, Phispers has more updates on the AstraZeneca-Oxford vaccine which continues to be mired in controversies. Earlier this week, Astra had said its jab was found to be 79 percent effective in preventing symptomatic illness in a larg...

2021-03-25

#Phispers by PHARMACOMPASS

#Blog

AstraZeneca’s Covid jab faces crisis of confidence as Europe halts vaccinations due to adverse events

The AstraZeneca-Oxford adenovirus vaccine has been embroiled in controversies ever since the drugmaker announced results from its clinical trial in November last year. The curious case of AstraZeneca’s jab got curiouser recently when over a doz...

2021-03-18

#Phispers by PHARMACOMPASS

#Blog

Novavax’s Covid vaccine shows 96 percent efficacy; GSK-Merck’s US$ 4.2 billion cancer drug flops again

This week, Phispers brings you news on Novavax’s Covid-19 vaccine that has proven to be 96 percent effective in preventing the disease caused by the original strain of the virus in a late-stage trial conducted in the UK. The jab was 86 percent ...

2021-03-18

#Phispers by PHARMACOMPASS

#Blog

Teva’s anti-competitive practices under EU scanner; FDA calls out Khloé Kardashian for making false claims

This week, Phispers brings you news of backlash over Biden administration’s plans to leverage the “full power” of its Defense Production Act to acquire more raw materials for the Pfizer-BioNTech vaccine. The world’s largest ma...

2021-03-11

#Phispers by PHARMACOMPASS

#Blog

US, EU announce plans to fortify drug supply chains; FDA authorizes J&J’s single shot vaccine

This week, Phispers brings you news on how the pandemic has compelled both the US and the EU to focus on strengthening their supply chains, particularly for drugs. There was also plenty of news on J&J’s single-shot Covid vaccine, as the US ...

2021-03-04

#Phispers by PHARMACOMPASS

#Blog

Indian drugmakers reducing dependence on China for APIs; Pfizer seeks FDA ok to store jab in standard freezers

This week, Phispers has lots of updates on the Pfizer-BioNTech vaccine. The two companies have asked the US Food and Drug Administration (FDA) to relax storage norms for their vaccine and allow it to be stored in pharmacy freezers, instead of ultr...

2021-02-25

#Phispers by PHARMACOMPASS

Blog: All Pharma Articles

#Phispers - PharmaCompass' Weekly News Recap of key industry developments so that users can quickly update themselves to be in the know.

#PharmaFlow - PharmaCompass' Data Compilation of Major Pharma & Biotech Deals. We offer Free Excel Compilations for users to perform their own analysis.

#SpeakPharma - PharmaCompass' Q&A where we follow fast-growing, innovative companies and profile them to make our users aware about new innovative capabilities and developments.

#RadioData - PharmaCompass' Data Compilations of Product & Company Sales, Non Compliances, New Drug Launches, FDA Facility Registrations, Medicare Sales Data etc. We offer Free Excel Compilations for users to perform their own analysis.

Access
Interactive
Dashboards

Access
All Data

Find

Blog & Analysis #Phispers #PharmaFlow

FDA halts production at J&J’s vaccine contractor for unsafe practices; Thermo Fisher picks up PPD for US$ 17.4 billion

Vaccine cocktails in the works: UK, China, France consider mixing jabs; India bans exports of remdesivir

Europe confirms link between Astra jab and clots; Baltimore plant mixes ingredients of J&J, Astra shots

Novartis shutters plant of world’s costliest drug; Bharat Biotech’s vaccine rejected by Anvisa due to GMP concerns

Chinese prices of APIs increase dramatically; former Operation Warp Speed head accused of sexual harassment

AstraZeneca’s Covid jab faces crisis of confidence as Europe halts vaccinations due to adverse events

Novavax’s Covid vaccine shows 96 percent efficacy; GSK-Merck’s US$ 4.2 billion cancer drug flops again

Teva’s anti-competitive practices under EU scanner; FDA calls out Khloé Kardashian for making false claims

US, EU announce plans to fortify drug supply chains; FDA authorizes J&J’s single shot vaccine

Indian drugmakers reducing dependence on China for APIs; Pfizer seeks FDA ok to store jab in standard freezers

Blog: All Pharma Articles

What are you looking for?

Find

Blog: All Pharma Articles

Most Read

What are you looking for?